79 related articles for article (PubMed ID: 38502695)
1. CEACAM6 expression and function in tumor biology: a comprehensive review.
Zhao D; Cai F; Liu X; Li T; Zhao E; Wang X; Zheng Z
Discov Oncol; 2024 May; 15(1):186. PubMed ID: 38796667
[TBL] [Abstract][Full Text] [Related]
2. Study on the Characteristics of Coarse Feeding Tolerance of Ding'an Pigs: Phenotypic and Candidate Genes Identification.
Song Y; Xue M; Wang F; Tang Q; Luo Y; Zheng M; Wang Y; Xue P; Dong N; Sun R; Fang M
Genes (Basel); 2024 May; 15(5):. PubMed ID: 38790227
[TBL] [Abstract][Full Text] [Related]
3. Carcinoembryonic antigen-related cell adhesion molecules (CEACAMs) in cancer progression and metastasis.
Beauchemin N; Arabzadeh A
Cancer Metastasis Rev; 2013 Dec; 32(3-4):643-71. PubMed ID: 23903773
[TBL] [Abstract][Full Text] [Related]
4. The emerging roles of CEACAM6 in human cancer (Review).
Wu G; Wang D; Xiong F; Wang Q; Liu W; Chen J; Chen Y
Int J Oncol; 2024 Mar; 64(3):. PubMed ID: 38240103
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic screen of sixty-eight colorectal cancer cell lines identifies CEACAM6 and CEACAM5 as markers of acid resistance.
Michl J; White B; Monterisi S; Bodmer WF; Swietach P
Proc Natl Acad Sci U S A; 2024 Mar; 121(13):e2319055121. PubMed ID: 38502695
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-6 trans-signaling increases the expression of carcinoembryonic antigen-related cell adhesion molecules 5 and 6 in colorectal cancer cells.
Holmer R; Wätzig GH; Tiwari S; Rose-John S; Kalthoff H
BMC Cancer; 2015 Dec; 15():975. PubMed ID: 26673628
[TBL] [Abstract][Full Text] [Related]
7. Expression patterns of CEACAM5 and CEACAM6 in primary and metastatic cancers.
Blumenthal RD; Leon E; Hansen HJ; Goldenberg DM
BMC Cancer; 2007 Jan; 7():2. PubMed ID: 17201906
[TBL] [Abstract][Full Text] [Related]
8. CEACAM5 and CEACAM6 are major target genes for Smad3-mediated TGF-beta signaling.
Han SU; Kwak TH; Her KH; Cho YH; Choi C; Lee HJ; Hong S; Park YS; Kim YS; Kim TA; Kim SJ
Oncogene; 2008 Jan; 27(5):675-83. PubMed ID: 17653079
[TBL] [Abstract][Full Text] [Related]
9. Overexpression and clinical significance of carcinoembryonic antigen-related cell adhesion molecule 6 in colorectal cancer.
Kim KS; Kim JT; Lee SJ; Kang MA; Choe IS; Kang YH; Kim SY; Yeom YI; Lee YH; Kim JH; Kim KH; Kim CN; Kim JW; Nam MS; Lee HG
Clin Chim Acta; 2013 Jan; 415():12-9. PubMed ID: 22975528
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of adhesion, invasion, and metastasis by antibodies targeting CEACAM6 (NCA-90) and CEACAM5 (Carcinoembryonic Antigen).
Blumenthal RD; Hansen HJ; Goldenberg DM
Cancer Res; 2005 Oct; 65(19):8809-17. PubMed ID: 16204051
[TBL] [Abstract][Full Text] [Related]
11. Acid-adapted cancer cells alkalinize their cytoplasm by degrading the acid-loading membrane transporter anion exchanger 2, SLC4A2.
Michl J; Monterisi S; White B; Blaszczak W; Hulikova A; Abdullayeva G; Bridges E; Yin Z; Bodmer WF; Swietach P
Cell Rep; 2023 Jun; 42(6):112601. PubMed ID: 37270778
[TBL] [Abstract][Full Text] [Related]
12. GMMchi: gene expression clustering using Gaussian mixture modeling.
Liu TC; Kalugin PN; Wilding JL; Bodmer WF
BMC Bioinformatics; 2022 Nov; 23(1):457. PubMed ID: 36324085
[TBL] [Abstract][Full Text] [Related]
13. Lipogenesis mediated by OGR1 regulates metabolic adaptation to acid stress in cancer cells via autophagy.
Pillai S; Mahmud I; Mahar R; Griffith C; Langsen M; Nguyen J; Wojtkowiak JW; Swietach P; Gatenby RA; Bui MM; Merritt ME; McDonald P; Garrett TJ; Gillies RJ
Cell Rep; 2022 May; 39(6):110796. PubMed ID: 35545051
[TBL] [Abstract][Full Text] [Related]
14. CRISPR-Cas9 screen identifies oxidative phosphorylation as essential for cancer cell survival at low extracellular pH.
Michl J; Wang Y; Monterisi S; Blaszczak W; Beveridge R; Bridges EM; Koth J; Bodmer WF; Swietach P
Cell Rep; 2022 Mar; 38(10):110493. PubMed ID: 35263578
[TBL] [Abstract][Full Text] [Related]
15. T cell-mediated elimination of cancer cells by blocking CEACAM6-CEACAM1 interaction.
Pinkert J; Boehm HH; Trautwein M; Doecke WD; Wessel F; Ge Y; Gutierrez EM; Carretero R; Freiberg C; Gritzan U; Luetke-Eversloh M; Golfier S; Von Ahsen O; Volpin V; Sorrentino A; Rathinasamy A; Xydia M; Lohmayer R; Sax J; Nur-Menevse A; Hussein A; Stamova S; Beckmann G; Glueck JM; Schoenfeld D; Weiske J; Zopf D; Offringa R; Kreft B; Beckhove P; Willuda J
Oncoimmunology; 2022; 11(1):2008110. PubMed ID: 35141051
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
